Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?
about
Lymphatic Vessels, Inflammation, and Immunity in Skin CancerInhibition of Immune Checkpoints and Vascular Endothelial Growth Factor as Combination Therapy for Metastatic Melanoma: An Overview of Rationale, Preclinical Evidence, and Initial Clinical DataCancer immunotherapy comes of ageThe TLR7 agonist imiquimod induces anti-cancer effects via autophagic cell death and enhances anti-tumoral and systemic immunity during radiotherapy for melanoma.Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumorsAntibody therapies for melanoma: new and emerging opportunities to activate immunity (Review).Combining targeted therapy with immunotherapy in BRAF-mutant melanoma: promise and challengesCharacterization of human γδ T lymphocytes infiltrating primary malignant melanomas.Targeted agents for the treatment of metastatic melanoma.Skewed Differentiation of Circulating Vγ9Vδ2 T Lymphocytes in Melanoma and Impact on Clinical Outcome.High endothelial venules (HEVs) in human melanoma lesions: Major gateways for tumor-infiltrating lymphocytesPotentiation of immunomodulatory antibody therapy with oncolytic viruses for treatment of cancer.Intravenous delivery of siRNA targeting CD47 effectively inhibits melanoma tumor growth and lung metastasis.Immunological monitoring of the tumor immunoenvironment for clinical trials.The role of the adenosinergic pathway in immunosuppression mediated by human regulatory T cells (Treg).Tumor microenvironment and lymphocyte infiltration.Microenvironment and tumor progression of melanoma: new therapeutic prospectives.Immune classification of colorectal cancer patients: impressive but how complete?Ret transgenic mouse model of spontaneous skin melanoma: focus on regulatory T cells.Prognostic and predictive significance of immune cells infiltrating cutaneous melanoma.Immunoplasticity in cutaneous melanoma: beyond pure morphology.Plasma cells in primary melanoma. Prognostic significance and possible role of IgA.Chemoattractant Receptors BLT1 and CXCR3 Regulate Antitumor Immunity by Facilitating CD8+ T Cell Migration into Tumors.VEGF Neutralization Plus CTLA-4 Blockade Alters Soluble and Cellular Factors Associated with Enhancing Lymphocyte Infiltration and Humoral Recognition in Melanoma.Targeted therapy and immunotherapy in advanced melanoma: an evolving paradigm.T-Cell Mediated Immune Responses Induced in ret Transgenic Mouse Model of Malignant Melanoma.Expression of TLR3, 4, 7 and 9 in cutaneous malignant melanoma: relationship with clinicopathological characteristics and prognosis.Immune biomarkers for prognosis and prediction of responses to immune checkpoint blockade in cutaneous melanoma.
P2860
Q26778332-733DD3C4-8BE6-4168-B90A-F9BFA4389405Q26781098-49BDD0A5-0FD9-432B-A6BE-CC543E83CD8EQ29619918-C1AC0926-A912-4984-8E24-404B228047C4Q33648709-F10D8ADA-8250-46A3-B9ED-E95A3D07719CQ33765767-4B6185F6-B323-47AC-A0FA-DA3715E0D7A3Q34000700-2D6E54D7-7E14-445E-A3A1-BC31E46E046EQ34185078-4D96E918-C9A0-4E47-8939-BDC860F8A891Q34493921-5A8D38EB-CBA1-4FEA-A078-67E49485D891Q35822194-988F0837-3006-4680-BB13-1F0720A786ECQ35935862-465F3FB0-A2F6-4107-9579-BB7939D7E72AQ36373347-F0BBDA44-460F-465C-945E-3E2A4F295E9AQ36664213-B54C3278-4D4E-408A-AD97-B5ECA3DEAAC3Q37254863-67F9BB18-7DF6-4316-A3B0-F0FD2BF30681Q37955680-856646D9-8BF5-49B2-BCDB-04FCA71B2AD6Q37956691-3CE5FD74-34D8-4A8A-BC59-4E901508D29CQ38001321-10D04718-7004-459D-9C88-67672794FEC3Q38049368-2EFB6434-52D8-48C1-87CA-09A5C4486BD4Q38071673-EEEC38F0-7B07-4A8D-9413-AA7642E11879Q38096466-91AB72F9-15FE-4931-A822-E63D62E84427Q38394496-29C50EE8-30C9-442B-86C8-464E54144F81Q39067933-D1C30440-7C7D-4EED-B625-C05D4BD18A7DQ40915404-AC88773B-3D18-45C7-AE83-65EBC48FBF7EQ41483538-CF708D1A-D97B-4B7A-87AD-6B5E2F5A482AQ41636554-3141CEEC-1787-4E18-8FD8-E10D1991E4CDQ41859238-4A483B83-7016-4515-B1BE-890D253A276EQ43089933-9C50F2F1-F5DE-415F-8DD3-9629E59EE473Q44484748-996AB632-A802-4BAA-8B85-7425C6C7D049Q53068034-F453C69B-87BC-42DA-8DBB-B9E8B89F1FE2
P2860
Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?
@en
Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?
@nl
type
label
Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?
@en
Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?
@nl
prefLabel
Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?
@en
Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?
@nl
P2093
P2860
P1476
Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?
@en
P2093
Arcadi Cipponi
Grégoire Wieers
Nicolas van Baren
Pierre G Coulie
P2860
P2888
P304
P356
10.1007/S00262-011-1026-2
P577
2011-05-07T00:00:00Z